M.D. Anderson Cancer Center: all 3,044 studies

Page 17 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate CancerActive, not recruitingNCT05055843Not applicable
• A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630Active, not recruitingNCT05055050Phase 1
• Parental Attitudes and Beliefs Regarding Risks Associated With Opioid Use in Children With CancerActive, not recruitingNCT05055011
• Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain MetastasesCompletedNCT05054998Phase 4
• Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MRWithdrawnNCT05054400Early Phase 1
• TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal CancerActive, not recruitingNCT05053750Early Phase 1
• Utilization of a Peer-Based Approach for the Promotion of Physical Activity in Inactive WomenActive, not recruitingNCT05053113Not applicable
• Increasing Access to Smoking Cessation and Smoke Free Home Services for Low-Income Pregnant Women in Northeast TexasTerminatedNCT05051345Not applicable
• Nutrition and Physical Activity Intervention in Preventing Excess Weight Gain in Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or DexamethasoneCompletedNCT05049785Early Phase 1
• Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant ChemotherapyActive, not recruitingNCT05049746Not applicable
• Communication Skills to Build a Diverse Biomedical WorkforceWithdrawnNCT05048290Not applicable
• An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate CancerActive, not recruitingNCT05047965Early Phase 1
• Comprehensive Evaluation of Tumor Oxygenation, Metabolism and Blood Supply of High Grade Glioma and Cervical Cancers Using Dynamic FAZA PET and Multiparametric MRActive, not recruitingNCT05047913Early Phase 1
• Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With HistopathologyWithdrawnNCT05046782Phase 2
• Contrast-Enhanced Mammography for the Evaluation of Mammographic MicrocalcificationsActive, not recruitingNCT05046301
• Feasibility Study of Anatomical Modeling for Image Guided Thoracic SurgeryCompletedNCT05046067Not applicable
• Impact of Aminoglycosides in Hypotensive Septic Oncology PatientsCompletedNCT05045963
• Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung CancerWithdrawnNCT05045404Phase 2
• EXPAREL or Lidocane as Local Anesthetic in Patients Undergoing Pleuroscopy With Pleural Biopsy and Indwelling Pleural Catheter PlacementActive, not recruitingNCT05044468Phase 2
• Sleep Disturbances in Surgical Patients With GI Cancers: A Quantitative and Qualitative AnalysisWithdrawnNCT05044312Not applicable
• Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing SarcomaWithdrawnNCT05042934Phase 1/2
• Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled TrialCompletedNCT05041946Phase 3
• Myofascial Release or Trigger Point Injections for the Reduction of Post-Mastectomy Pain SyndromeWithdrawnNCT05041751Not applicable
• Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal AdenocarcinomaActive, not recruitingNCT05041153Early Phase 1
• Cetuximab for the Treatment of Advanced Unresectable or Metastatic ChordomaActive, not recruitingNCT05041127Phase 2
• A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE (MRD)CompletedNCT05040568Phase 1
• A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line TherapyWithdrawnNCT05039736Phase 2
• Atezolizumab and Cabozantinib for the Treatment of Recurrent GlioblastomaActive, not recruitingNCT05039281Phase 1/2
• Acceptability of Mobile Applications (Apps) to Enhance Smoking Cessation in a Clinical Tobacco Treatment Program - A Pilot StudyActive, not recruitingNCT05038852Not applicable
• Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid TumorsCompletedNCT05038839Phase 1
• Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic SyndromesActive, not recruitingNCT05038592Phase 1/2
• Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at WorkWithdrawnNCT05038384
• Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse EventsActive, not recruitingNCT05038254Not applicable
• ProvoxLife Adoption Trends for Heat-Moisture ExchangerActive, not recruitingNCT05036330
• DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual DiseaseCompletedNCT05036109Not applicable
• A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study)WithdrawnNCT05035732Not applicable
• Anti-Leukemia Immune Responses After Irradiation of Extramedullary TumorsActive, not recruitingNCT05035706Early Phase 1
• Patient Considerations of Social Media Account Management After DeathActive, not recruitingNCT05035667
• Gallium-68 PSMA-11 PET in Participants With Prostate CancerWithdrawnNCT05034562Phase 2
• Fostamatinib for the Treatment of Lower-risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia Who Have Failed Therapy with Hypomethylating AgentsCompletedNCT05030675Phase 1
• ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin LymphomaActive, not recruitingNCT05025800Phase 1/2
• Exercise During Chemotherapy in Older Women With Stage I-III Breast CancerActive, not recruitingNCT05025059Not applicable
• Evaluating Shared Decision-Making for Lung Cancer Screening Among Chinese Populations in the United StatesWithdrawnNCT05024955
• Metformin and Nightly Fasting in Women With Early Breast CancerActive, not recruitingNCT05023967Phase 2
• Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME StudyWithdrawnNCT05022394Phase 1/2
• Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung CancerCompletedNCT05017025Phase 1/2
• Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell CancerActive, not recruitingNCT05012371Phase 2
• BAY1895344 and Copanlisib for the Treatment of Molecularly Selected Patients With Advanced Solid TumorsWithdrawnNCT05010096Phase 1
• ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic PhaseActive, not recruitingNCT05007873Phase 2
• Comparing the Performance of Automated Breast Ultrasonography to Hand-Held Whole Breast Ultrasonography in Breast Cancer Treatment Response AssessmentWithdrawnNCT05005936
• Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid NoduleTerminatedNCT05003856Not applicable
• Contemporary Characteristics of Penile CancerTerminatedNCT04996849
• Feasibility of Mobile-CT-Assisted Bronchoscopy for the Diagnosis of Lung LesionCompletedNCT04995172
• An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid TumorsActive, not recruitingNCT04993261Early Phase 1
• Venetoclax and Eprenetapopt for the Treatment of Relapsed of Refractory Mantle Cell LymphomaWithdrawnNCT04990778Phase 2
• Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint InhibitorsActive, not recruitingNCT04990726
• Technology-Enhanced Palliative Care for Advanced Cancer PatientsActive, not recruitingNCT04989556Not applicable
• Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING StudyWithdrawnNCT04987281Phase 2
• Neoadjuvant Dietary Intervention in Intermediate Risk Prostate CancerActive, not recruitingNCT04985565Not applicable
• An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate CancerCompletedNCT04978675Phase 1
• Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop StudyActive, not recruitingNCT04978584Phase 2
• Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaActive, not recruitingNCT04975919Phase 2
• Fecal Microbial Transplants for the Treatment of Pancreatic CancerSuspendedNCT04975217Early Phase 1
• AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic CancerCompletedNCT04973683Phase 1
• Nivolumab and ADI-PEG 20 Before Surgery for the Treatment of Resectable Liver CancerWithdrawnNCT04965714Phase 2
• Nivolumab for the Treatment of Metastatic or Unresectable Solid Tumors With ARID1A Mutation and CXCL13 ExpressionActive, not recruitingNCT04957615Phase 2
• ARID1A and/or KDM6A Mutation and CXCL13 ExpressionActive, not recruitingNCT04953104Phase 2
• Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaActive, not recruitingNCT04940299Phase 2
• Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic CancerActive, not recruitingNCT04940286Phase 2
• Liposomal Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin for the Treatment of Relapsed Refractory Pediatric Patients With Acute Myeloid LeukemiaCompletedNCT04915612Phase 1
• Effect of Materials for Subcuticular Suture (Quill vs. Monocryl) on Complications After Liver ResectionStatus unknownNCT04906174
• Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell CancerTerminatedNCT04904302Phase 2
• Dyadic Yoga Intervention for the Improvement of Healthcare Utilization and Quality of Life in Patients With Head and Neck Cancer Undergoing Chemoradiation and Their CaregiversActive, not recruitingNCT04890834Not applicable
• The Impact of an Antibiotic (Cefazolin) Before Surgery on the Microbiome in Patients With Stage I-II MelanomaActive, not recruitingNCT04875728Phase 1
• Patient Reported Symptom Control With THC or CBD UseActive, not recruitingNCT04875286
• Patient Reported Outcome Post Radiation Therapy or Chemoradiotherapy Patient Care in Patients With Oropharyngeal CancerActive, not recruitingNCT04874493
• Tegavivint for the Treatment of Relapsed or Refractory LeukemiaActive, not recruitingNCT04874480Phase 1
• Interrogating Biological Signaling Pathway Dysregulations and In Vitro Screening With Personalized Therapies in Relapsed or Refractory Mantle Cell Lymphoma, MCL MATCH TrialCompletedNCT04872413Not applicable
• An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast CancerActive, not recruitingNCT04871139Not applicable
• Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck CancerCompletedNCT04870840Phase 1
• Mindfulness-Based Intervention for Latino Cancer Patients and Their CaregiversActive, not recruitingNCT04870788Not applicable
• Customized 3D Printed Oral Stents During Head and Neck RadiotherapyActive, not recruitingNCT04870762Phase 2
• NBTXR3, Radiation Therapy, and Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell CancerTerminatedNCT04862455Phase 2
• Itacitinib for the Prevention of Graft Versus Host DiseaseActive, not recruitingNCT04859946Phase 2
• Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung CancerActive, not recruitingNCT04837716Phase 1
• Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength StudyActive, not recruitingNCT04837118Not applicable
• Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant ChemotherapyTerminatedNCT04835597
• Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell CancerWithdrawnNCT04834349Phase 2
• Development of a Patient Decision Aid for Women Considering Breast ReconstructionCompletedNCT04817709
• Positive Activities Intervention to Improve Quality of Life in Collectivist Culture Cancer Patients and Their CaregiversCompletedNCT04810052Not applicable
• A Smoking Prevention Program (ASPIRE) and Mentoring for Preventing Smoking Among High School YouthsCompletedNCT04803682Early Phase 1
• What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven CareWithdrawnNCT04794816
• Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver CirrhosisActive, not recruitingNCT04785534Not applicable
• Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid MalignanciesTerminatedNCT04785287Phase 1/2
• Ipilimumab, Ibrutinib, and Nivolumab for the Treatment of Chronic Lymphocytic Leukemia and Richter TransformationWithdrawnNCT04781855Phase 1
• Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid SyndromeWithdrawnNCT04776876Phase 2
• Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe HemoglobinopathiesWithdrawnNCT04776850Early Phase 1
• Effect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic LeukemiaCompletedNCT04774744Not applicable
• Acalabrutinib and Rituximab for the Treatment of Previously Untreated Mantle Cell LymphomaActive, not recruitingNCT04765111Phase 2
• Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid CancerActive, not recruitingNCT04759911Phase 2

← M.D. Anderson Cancer Center overview and focus areas